Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 2/2009

01.06.2009 | Original Article

An intensive nurse-led, multi-interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care

verfasst von: J. MacMahon Tone, A. Agha, M. Sherlock, F. Finucane, W. Tormey, C. J. Thompson

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of this research was to determine whether an intensive, nurse-led clinic could achieve recommended vascular risk reduction targets in patients with type 2 diabetes as compared to standard diabetes management.

Method

Two hundred patients with type 2 diabetes were recruited to receive either intensive nurse-led or standard diabetes care in a 1-year open study.

Results

In each group 94 patients completed the study. The groups were matched for age and baseline HbA1c, blood pressure and lipid profiles. More patients in the intensive group achieved vascular risk targets than in the standard group: SBP (<130 mmHg) 33 versus 12.1%, (P < 0.001); DBP (<80 mmHg) 75.5 versus 40.2%, (P < 0.001); cholesterol (<4.8 mmol/L) 84.8 versus 63.6% (P = 0.003); LDL (<2.6 mmol/L) 73.4 versus 54.5% (P = 0.007); HbA1c (<6.5%) 53.2 versus 32.9% (P = 0.005).

Conclusion

An intensive nurse-led clinic is more successful in achieving vascular risk targets than standard diabetes care.
Literatur
1.
Zurück zum Zitat International Diabetes Foundation (2003) Diabetes atlas, 2nd edn. Executive summary. International Diabetes Foundation, Brussels, p 8 International Diabetes Foundation (2003) Diabetes atlas, 2nd edn.  Executive summary. International Diabetes Foundation, Brussels, p 8
3.
Zurück zum Zitat Institute of Public Health in Ireland (2006) Making diabetes count, a systematic approach to estimating population prevalence on the island of Ireland in 2005. First report of the Irish Diabetes Prevalence Working Group, Ireland and Northern Ireland’s Population Health Observatory (INIsPHO), Dublin Institute of Public Health in Ireland (2006) Making diabetes count, a systematic approach to estimating population prevalence on the island of Ireland in 2005. First report of the Irish Diabetes Prevalence Working Group, Ireland and Northern Ireland’s Population Health Observatory (INIsPHO), Dublin
7.
Zurück zum Zitat Curb JD, Pressel SL, Cutler JA, For the Systolic Hypertension in the Elderly Program Cooperative Research Group (SHEP) et al (1996) Effect of diuretic-based anti-hypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 276:1886–1892. doi:10.1001/jama.276.23.1886 PubMedCrossRef Curb JD, Pressel SL, Cutler JA, For the Systolic Hypertension in the Elderly Program Cooperative Research Group (SHEP) et al (1996) Effect of diuretic-based anti-hypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 276:1886–1892. doi:10.​1001/​jama.​276.​23.​1886 PubMedCrossRef
9.
Zurück zum Zitat Hansson L, Zanchetti A, Carruthers SG et al (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. HOT Study Group. Lancet 351:1755–1762. doi:10.1016/S0140-6736(98)04311-6 PubMedCrossRef Hansson L, Zanchetti A, Carruthers SG et al (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. HOT Study Group. Lancet 351:1755–1762. doi:10.​1016/​S0140-6736(98)04311-6 PubMedCrossRef
10.
Zurück zum Zitat UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317:703–713 UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317:703–713
11.
Zurück zum Zitat UK Prospective Diabetes Study Group (1998) Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39). BMJ 317:713–720 UK Prospective Diabetes Study Group (1998) Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39). BMJ 317:713–720
12.
Zurück zum Zitat ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: the anti-hypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 288:2981–2997. doi:10.1001/jama.288.23.2981 CrossRef ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: the anti-hypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 288:2981–2997. doi:10.​1001/​jama.​288.​23.​2981 CrossRef
13.
Zurück zum Zitat Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383–1389 Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383–1389
14.
Zurück zum Zitat Shepherd J, Cobbe SM, Ford I, West of Scotland Coronary Prevention Study Group (WOSCOPS) et al (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301–1307. doi:10.1056/NEJM199511163332001 PubMedCrossRef Shepherd J, Cobbe SM, Ford I, West of Scotland Coronary Prevention Study Group (WOSCOPS) et al (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301–1307. doi:10.​1056/​NEJM199511163332​001 PubMedCrossRef
15.
Zurück zum Zitat Sacks FR, Pfeffer MA, Moye LA, Cholesterol and Recurrent Events Trial Investigators (CARE) et al (1996) The effect of Pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335:1001–1009. doi:10.1056/NEJM199610033351401 PubMedCrossRef Sacks FR, Pfeffer MA, Moye LA, Cholesterol and Recurrent Events Trial Investigators (CARE) et al (1996) The effect of Pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335:1001–1009. doi:10.​1056/​NEJM199610033351​401 PubMedCrossRef
16.
Zurück zum Zitat Heart Protection Study Collaborative Group (2002) MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7–22. doi:10.1016/S0140-6736(02)09327-3 CrossRef Heart Protection Study Collaborative Group (2002) MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7–22. doi:10.​1016/​S0140-6736(02)09327-3 CrossRef
17.
Zurück zum Zitat Sever PD, Dahlof B, Poulter NR et al (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian cardiac outcomes trial-lipid lowering arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361:977–986. doi:10.1016/S0140-6736(03)12837-1 CrossRef Sever PD, Dahlof B, Poulter NR et al (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian cardiac outcomes trial-lipid lowering arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361:977–986. doi:10.​1016/​S0140-6736(03)12837-1 CrossRef
18.
Zurück zum Zitat Colhoun HM, Betteridge DJ, Durrington PN, CARDS Investigators et al (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685–696. doi:10.1016/S0140-6736(04)16895-5 PubMedCrossRef Colhoun HM, Betteridge DJ, Durrington PN, CARDS Investigators et al (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685–696. doi:10.​1016/​S0140-6736(04)16895-5 PubMedCrossRef
20.
Zurück zum Zitat Campos C (2007) Treating the whole patient for optimal management of type 2 diabetes: considerations for insulin therapy. South Med J 100(8):804–811PubMed Campos C (2007) Treating the whole patient for optimal management of type 2 diabetes: considerations for insulin therapy. South Med J 100(8):804–811PubMed
26.
Zurück zum Zitat Sherlock M, Mylotte D, Mac Mahon J et al (2006) Lipid lowering targets are easier to attain than those for treatment of hypertension. Ir J Med Sci 175(4):36–41PubMedCrossRef Sherlock M, Mylotte D, Mac Mahon J et al (2006) Lipid lowering targets are easier to attain than those for treatment of hypertension. Ir J Med Sci 175(4):36–41PubMedCrossRef
27.
29.
31.
Zurück zum Zitat American Diabetes Association, Position Statement (2001) Standards of medical care for patients with diabetes mellitus. Diabetes Care 24(Supp 1):S33–S43. doi:10.2337/diacare.24.1.33 American Diabetes Association, Position Statement (2001) Standards of medical care for patients with diabetes mellitus. Diabetes Care 24(Supp 1):S33–S43. doi:10.​2337/​diacare.​24.​1.​33
33.
Zurück zum Zitat American Diabetes Association (1997) Aspirin therapy in diabetes (position statement). Diabetes Care 20:1772–1773 American Diabetes Association (1997) Aspirin therapy in diabetes (position statement). Diabetes Care 20:1772–1773
37.
Zurück zum Zitat Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes, a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 29(8):1963–1972. doi:10.2337/dc06-9912 PubMedCrossRef Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes, a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 29(8):1963–1972. doi:10.​2337/​dc06-9912 PubMedCrossRef
38.
Zurück zum Zitat Nolan JJ, O’Halloran D, McKenna TJ et al (2006) The cost of treating type 2 diabetes (CODEIRE). Ir Med J 99(10):307–310PubMed Nolan JJ, O’Halloran D, McKenna TJ et al (2006) The cost of treating type 2 diabetes (CODEIRE). Ir Med J 99(10):307–310PubMed
39.
Zurück zum Zitat Fontbonne A, Eschwege E, Cambien F et al (1989) Hypertriglyceridaemia as a risk factor of coronary heart disease; mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32:300–304. doi:10.1007/BF00265546 PubMedCrossRef Fontbonne A, Eschwege E, Cambien F et al (1989) Hypertriglyceridaemia as a risk factor of coronary heart disease; mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32:300–304. doi:10.​1007/​BF00265546 PubMedCrossRef
42.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, National High Blood Pressure Education Program Coordinating Committee et al (2003) The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. JAMA 289:2560–2571. doi:10.1001/jama.289.19.2560 PubMedCrossRef Chobanian AV, Bakris GL, Black HR, National High Blood Pressure Education Program Coordinating Committee et al (2003) The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. JAMA 289:2560–2571. doi:10.​1001/​jama.​289.​19.​2560 PubMedCrossRef
43.
Zurück zum Zitat Lewington S, Clarke R, Qizilbash N et al (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913. doi:10.1016/S0140-6736(02)11911-8 PubMedCrossRef Lewington S, Clarke R, Qizilbash N et al (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913. doi:10.​1016/​S0140-6736(02)11911-8 PubMedCrossRef
45.
Zurück zum Zitat Kaplan NM (2001) Management of hypertension in patients with type 2 diabetes mellitus: guidelines based on current evidence. Ann Intern Med 135:1079–1083PubMed Kaplan NM (2001) Management of hypertension in patients with type 2 diabetes mellitus: guidelines based on current evidence. Ann Intern Med 135:1079–1083PubMed
46.
Zurück zum Zitat IDF Clinical Guidelines Task Force (2005) Global guideline for type 2 diabetes. International Diabetes Federation, Brussels, pp 35–38 IDF Clinical Guidelines Task Force (2005) Global guideline for type 2 diabetes. International Diabetes Federation, Brussels, pp 35–38
48.
Zurück zum Zitat The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986. doi:10.1056/NEJM199309303291401 CrossRef The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986. doi:10.​1056/​NEJM199309303291​401 CrossRef
49.
Zurück zum Zitat The UK Prospective Diabetes Study (UKPDS) Group (1998) Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 317:720–726 The UK Prospective Diabetes Study (UKPDS) Group (1998) Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 317:720–726
50.
Zurück zum Zitat The UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853. doi:10.1016/S0140-6736(98)07019-6 CrossRef The UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853. doi:10.​1016/​S0140-6736(98)07019-6 CrossRef
Metadaten
Titel
An intensive nurse-led, multi-interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care
verfasst von
J. MacMahon Tone
A. Agha
M. Sherlock
F. Finucane
W. Tormey
C. J. Thompson
Publikationsdatum
01.06.2009
Verlag
Springer-Verlag
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 2/2009
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-009-0316-6

Weitere Artikel der Ausgabe 2/2009

Irish Journal of Medical Science (1971 -) 2/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.